Where do we stand on translating breakthrough science into therapeutic products? The session will feature leaders who have developed products using three of the most promising technology areas -- stem cells, RNA therapeutics and epigenetics. They will discuss progress and issues including selecting productive opportunities, effective crisis management, and progressing from R&D through commercialization of innovation.
- Explore how innovation and value are increasingly necessary for progress and approval
- Provide a realistic perspective on the issues and potential solutions from people who have succeeded
- Review the current state of this breakthrough science and how to apply it
Ability Level: All
Session ID: 2423